Conjugates of insulin-like growth factor1 (IGF-1) and poly(ethylene glycol)

Details for Australian Patent Application No. 2005318387 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Regula, Jorg; Lanzendoerfer,Martin; Kuenkele, Klaus-Peter; Schaubmar, Andreas; Amrein, Beat; Lang, Kurt; Hesse, Friederike; Foser, Stefan; Metzger, Friedrich

Agent Spruson & Ferguson

Pub. Number AU-B-2005318387

PCT Pub. Number WO2006/066891

Priority 04030415.6 22.12.04 EP

Filing date 21 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 21 July 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 July 2007 PCT application entered the National Phase

  PCT publication WO2006/066891 Priority application(s): WO2006/066891

21 July 2011 Application Accepted

  Published as AU-B-2005318387

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318388-Method for producing hydrogen and power from a synthesis gas

2005318384-Pumped foam containing alcohol